Canada needs to catch up in the biotech sector
Currently, our scientists have to look outside of the country to take their work to the next level, which means that Canada is not benefitting fully from Canadian ideas.
Unlocking Canada’s greatest economic potential: life sciences
The time has come for us to commit to life sciences as a driver for Canada’s economy with the knowledge that this sector can help solve some of our biggest societal challenges.
Canada’s biotech carpe diem
It’s imperative Canada keep pace with other competing jurisdictions, and establish itself as a regulatory leader that rewards investment and talent.
Harnessing the power of Canada’s growing biotechnology industry: a perspective from the West
Government investment and policy can help ensure groundbreaking technologies remain in Canada when companies scale up their production especially for international distribution.
Biotechnology: an opportunity balanced on a knife’s edge
To fully harness the benefits of a thriving biotechnology industry, it is critical we act to address the challenges that threaten it.
Biotechnology must factor into a broader Canadian industrial policy
Governments should focus on supporting basic research, helping startups, and funding the scale-up of growth companies.
From crisis to catalyst: Canada’s opportunity to drive global health and research innovation
By creating an environment that fuels scientific advancement, Canada can face future crises with confidence, ensuring both its prosperity and global influence.
A flourishing biotech sector starts by innovating education
Innovating graduate education to support a wider variety of career paths will be key to creating the talent we need to have a vibrant biotechnology ecosystem.
The prescription for Canada’s health care future
Focus on embracing the rapid pace of scientific discovery, letting innovation drive policy, and fostering collaboration across the health-care system.
Biotechnology momentum in Canada needs infusion of talent and anchor firms, say industry reps
Canada has several prominent life science firms, but none can be considered an anchor company, according to a report by the adMare Institute released in late 2023.
